| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |